Feedback / Questions
simufilam (PTI-125) - Cassava
https://www.globenewswire.com/news-release/2024/05/10/2879821/8339/en/Cassava-Sciences-Reports-Q1-2024-Financial-Results-and-Clinical-Updates-on-Phase-3-Trials-of-Simufilam.html
May 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next